Skip to content

Statistics

How PMS changes with age: the data

PMS prevalence estimates range from about 5% to 53%, depending on how strictly a study defines it, not mainly on age. A Swiss guideline puts PMDD, the more severe diagnosis, at 3 to 8% of women. Studies rarely break results down by exact age, since most group together everyone of reproductive age, from the teens to the late forties.

Updated Niyora editorial Mixed evidence

At a glance

  • PMS prevalence estimates span from about 5% to 53% across studies, mostly because of differing definitions, not age [1, 8].
  • A Swiss interdisciplinary consensus estimates 30 to 40% of women have PMS symptoms needing treatment, and 3 to 8% meet PMDD criteria [4].
  • Most prevalence studies group all reproductive-age women together rather than breaking results down by decade of life [1, 4, 6].
  • Country and study method, self-report versus daily tracking, explain more of the gap between estimates than age does.
  • Two months of your own daily symptom notes tells you more about your pattern than any published percentage [5].

53%

Pooled PMS prevalence across 9 studies in Ethiopia

Prevalence and associated factors of premenstrual syndrome among women of the re (2020)

30-40%

Women reporting PMS symptoms needing treatment, Swiss guideline

Interdisciplinary consensus on management of premenstrual disorders in switzerla (2019)

5%

Women with PMS symptoms severe enough to need professional help

Short report: cognitive behavioral therapy - a primary mode for premenstrual syn (2021)

Strength of evidence

Mixed evidence

Prevalence estimates range from 5% to 53% across reviews, driven mainly by differing definitions, study methods and countries rather than a single confirmed rate. Direct age-stratified prevalence data is limited in the current research, so claims about PMS peaking at a specific age aren't well supported yet.

What percentage of people are affected?

The share of women counted as having PMS swings widely between studies, landing anywhere from about 5% to 53%, because researchers set the bar in different places.

  • A meta-analysis of nine studies from Ethiopia (out of 33 screened) put pooled PMS prevalence at 53% among women of reproductive age [1].
  • A Swiss interdisciplinary consensus of gynecologists and psychiatrists estimates that 30 to 40% of women report PMS symptoms serious enough to want treatment, and that 3 to 8% meet criteria for PMDD, the more severe diagnosis [4].
  • A systematic review focused on cognitive behavioral therapy for PMS found that roughly 5% of women have symptoms severe enough to need professional help [8].

None of these numbers is wrong. They measure different things, from any premenstrual symptom at all, to symptoms someone would treat, to symptoms that get in the way of work and relationships. Even the lowest figure, about 5%, works out to roughly 1 in 20 women dealing with PMS severe enough to need professional support every cycle.

What do the largest studies find?

The most cited numbers come from a handful of large reviews that pooled dozens of smaller studies rather than from any single survey.

Study Scope What it found
Ethiopia meta-analysis [1] 9 studies, from 33 screened 53% pooled PMS prevalence among reproductive-age women
PMDD management scoping review [7] 194 studies Strongest evidence for SSRIs and combined oral contraceptives, with GnRH agonists and surgery showing efficacy for refractory cases [7]
Self-management systematic review [3] 39 studies, 3,806 participants Physical activity, especially yoga, most consistently eased mood and fatigue

These are reviews of reviews, so they carry more weight than a single survey of a few hundred women.

None of them report prevalence broken down by age in years.

Most describe participants simply as women of reproductive age, which can mean anywhere from the early teens to the late forties.

That matters for comparing countries, since 'reproductive age' studies may quietly include anyone from 15 to 49. The PMDD and PMS research library has more on the individual trials behind these pooled numbers.

How do the numbers vary by age and country?

Country matters more than age in the research we have. The Ethiopian pooled estimate of 53% [1] sits well above the Swiss estimate of 30 to 40% [4], and neither study broke results down by decade of life.

Age still matters to how PMS and PMDD show up and get treated.

Most prevalence studies recruit broadly from women of reproductive age rather than comparing, say, 18-year-olds to 35-year-olds, so any age pattern gets lost in the average.

Clinical guidelines handle age differently: ACOG's guideline covers reproductive-aged adults and adolescents together [6], and the Swiss consensus adjusts its treatment approach by reproductive stage, including the shift toward menopausal transition [2, 4].

A prospective study that specifically compared teenagers to women in their thirties and forties would settle this, but none of the reviews here include one.

So PMS can show up anywhere from the first few years after your first period through the years before menopause.

The research hasn't pinned down a single age when it peaks.

What may change with age is less the odds of having PMS and more which treatment a doctor reaches for first, since that depends on things like whether you're trying to conceive or approaching perimenopause.

For the fuller picture on PMS itself, see what PMS is.

Why do estimates differ so much?

Four things drive most of the gap between a 5% estimate and a 53% estimate for the same condition.

  • Definition: some studies count any premenstrual symptom, others only count symptoms severe enough to need treatment.
  • Method: a single retrospective survey asking whether you had symptoms last month tends to produce higher numbers than prospective daily tracking.
  • Sample: community surveys of all women differ from clinic samples of women already seeking help.
  • Country: reporting norms, language around premenstrual symptoms, and access to care all shift the number up or down.

Put these together and a study using a loose definition, a retrospective survey, a community sample, and a country with high symptom reporting will land near the high end of the range.

The opposite combination lands near the low end.

This is the same pattern seen with PMDD, where confirmed daily-tracking diagnoses, confirmed diagnoses overall, and provisional diagnoses produce three different percentages from the same underlying condition.

See how common PMDD is and the full PMS numbers for how these estimates are built study by study.

What do these numbers mean for you?

None of these percentages can tell you whether your own pattern is PMS, PMDD, or something else. Only your own tracking can do that.

If your symptoms ease within a few days of your period starting, you're part of the pattern that fits most of these studies, somewhere between mild and needing treatment. If five or more symptoms, including a mood symptom, show up every cycle and get in the way of work or relationships, that pattern is worth tracking closely enough to bring to a doctor.

Two simple steps get you a personal answer instead of a published range:

  1. Track mood, energy and physical symptoms daily for at least two cycles.
  2. Mark the day your period starts and watch whether symptoms ease within a few days of it.

PMDD itself gets diagnosed from your own charted cycles against DSM-5-TR criteria over two months, using the same kind of daily tracking [5].\n\nTo see your pattern without guesswork, Niyora is a PMS and PMDD support app that gives you an estimated PMS window and a space called Moon, where you can write down what happened on a day when it feels like too much, see it from another angle, and calm down before you respond.

Start your two months of notes today, and bring them to a doctor if the pattern holds.

From the research library

Research on prevalence

980 studies in the library look at prevalence in PMS and PMDD. They were published from 1964 to 2026, and each one has a short summary of what was tested and found.

980

studies, 1964 to 2026

How strong the studies are

Strong study design
46
Moderate study design
340
Early or limited evidence
594

See all 980 studies on prevalence and epidemiology

Questions people ask

What percentage of women get PMS?+

PMS prevalence estimates vary from about 5% to 53% depending on the study. A nine-study meta-analysis from Ethiopia found a pooled rate of 53% [1], while a Swiss guideline estimates 30 to 40% of women have symptoms needing treatment [4]. The gap comes from definition, not from one true rate.

Does PMS get worse with age?+

The research behind these prevalence numbers doesn't track PMS by exact age. Clinical guidelines instead adjust their approach across reproductive stages, including the shift toward perimenopause, so symptoms and treatment choices can change with age even though the overall PMS rate isn't clearly age-linked [2, 4].

Why do PMS statistics vary so much between countries?+

PMS statistics vary between countries partly from real differences in reporting and access to care, and partly from different study definitions. The Ethiopian pooled estimate of 53% [1] and the Swiss estimate of 30 to 40% [4] aren't measuring the exact same thing, so comparing them directly can mislead.

Is PMDD prevalence counted separately from PMS?+

Yes. PMDD is a distinct diagnosis needing at least five symptoms, including one mood symptom, confirmed by daily tracking over two cycles. A Swiss guideline puts PMDD prevalence at 3 to 8% of women, below broader PMS estimates [4].

Sources

  1. 1.Prevalence and associated factors of premenstrual syndrome among women of the reproductive age group in Ethiopia: Systematic review and meta-analysis, PloS one, 2020
  2. 2.Interdisciplinary consensus on management of premenstrual disorders in Switzerland, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017
  3. 3.Self-management strategies for menstrual cycle symptoms: a systematic review, BMC women's health, 2026
  4. 4.Interdisciplinary consensus on management of premenstrual disorders in switzerland, Reproductive Endocrinology, 2019
  5. 5.Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder, Archives of women's mental health, 2016
  6. 6.Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7, Obstetrics and gynecology, 2023
  7. 7.Management of Premenstrual Dysphoric Disorder: A Scoping Review, International journal of women's health, 2022
  8. 8.Short report: cognitive behavioral therapy - a primary mode for premenstrual syndrome management: systematic literature review, Psychology, health & medicine, 2021